Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
43.26 USD | -0.54% | -5.98% | -3.42% |
May. 21 | QIAGEN NV : Berenberg maintains a Buy rating | ZD |
May. 15 | Qiagen's Updated Clinical Decision Support Platform Secures EU Certification | MT |
Financials (USD)
Sales 2024 * | 2.01B | Sales 2025 * | 2.14B | Capitalization | 9.65B |
---|---|---|---|---|---|
Net income 2024 * | 407M | Net income 2025 * | 450M | EV / Sales 2024 * | 4.93 x |
Net Debt 2024 * | 251M | Net cash position 2025 * | 257M | EV / Sales 2025 * | 4.4 x |
P/E ratio 2024 * |
23.9
x | P/E ratio 2025 * |
21.5
x | Employees | 5,900 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.86% |
Latest transcript on Qiagen N.V.
1 day | -0.17% | ||
1 week | -5.77% | ||
Current month | +2.37% | ||
1 month | +3.45% | ||
3 months | -1.11% | ||
6 months | +2.80% | ||
Current year | -3.21% |
Managers | Title | Age | Since |
---|---|---|---|
Thierry Bernard
CEO | Chief Executive Officer | 60 | 15-01-31 |
Metin Colpan
FOU | Founder | 69 | 96-04-28 |
Roland Sackers
DFI | Director of Finance/CFO | 56 | 98-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 74 | 11-05-31 | |
Metin Colpan
FOU | Founder | 69 | 96-04-28 |
Lawrence Rosen
CHM | Chairman | 66 | 13-06-25 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
3.10% | 1 M€ | 0.00% | - | |
1.79% | 2 M€ | -.--% | ||
1.65% | 2 M€ | 0.00% | ||
1.32% | 144 M€ | +2.20% | - | |
1.08% | 8 M€ | 0.00% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-23 | 43.26 | -0.55% | 192 434 |
24-05-22 | 43.5 | -3.38% | 1,593,312 |
24-05-21 | 45.02 | -0.99% | 773,169 |
24-05-20 | 45.47 | -0.48% | 1,174,719 |
24-05-17 | 45.69 | -0.65% | 1,274,938 |
Delayed Quote Nyse, May 23, 2024 at 09:57 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.21% | 9.65B | |
+59.34% | 62.59B | |
-2.64% | 41.18B | |
+44.25% | 40.29B | |
-8.29% | 27.9B | |
+12.68% | 26.21B | |
-21.73% | 19.09B | |
+5.95% | 13.08B | |
+24.29% | 12.26B | |
+27.24% | 12.05B |
- Stock Market
- Equities
- QGEN Stock